Programmatic Addition of Clofazimine to Multidrug Therapy for Paucibacillary Leprosy in India: A One-Size-Fits-All Approach in Absence of Sound Clinical Evidence.

Jain A, Sharma S, Gupta V, Khaitan A

Open source

DOI
10.4269/ajtmh.25-0131
Published
2025 Sep 3
Container
The American journal of tropical medicine and hygiene
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4269/ajtmh.25-0131,
  title = {Programmatic Addition of Clofazimine to Multidrug Therapy for Paucibacillary Leprosy in India: A One-Size-Fits-All Approach in Absence of Sound Clinical Evidence.},
  author = {Jain A and Sharma S and Gupta V and Khaitan A},
  year = {2025},
  journal = {The American journal of tropical medicine and hygiene},
  doi = {10.4269/ajtmh.25-0131},
  url = {https://doi.org/10.4269/ajtmh.25-0131}
}

RIS

TY  - JOUR
TI  - Programmatic Addition of Clofazimine to Multidrug Therapy for Paucibacillary Leprosy in India: A One-Size-Fits-All Approach in Absence of Sound Clinical Evidence.
AU  - Jain A
AU  - Sharma S
AU  - Gupta V
AU  - Khaitan A
PY  - 2025
JO  - The American journal of tropical medicine and hygiene
DO  - 10.4269/ajtmh.25-0131
UR  - https://doi.org/10.4269/ajtmh.25-0131
ER  - 

APA

A, J., S, S., V, G., & A, K. (2025). Programmatic Addition of Clofazimine to Multidrug Therapy for Paucibacillary Leprosy in India: A One-Size-Fits-All Approach in Absence of Sound Clinical Evidence.. The American journal of tropical medicine and hygiene. https://doi.org/10.4269/ajtmh.25-0131

Source records